SBIR-STTR Award

Colloidal Quantum Dot/Well Near-Infrared NanoLabels
Award last edited on: 6/24/11

Sponsored Program
SBIR
Awarding Agency
NIH : NIBIB
Total Award Amount
$1,086,946
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Yongcheng Liu

Company Information

NN-Labs LLC (AKA: NanoLabs~Nanomaterials and Nanofabrication Laboratories~NanoMF~NN-Labs)

PO Box 2168
Fayetteville, AR 72701
   (479) 595-0662
   contact@nn-labs.com
   www.nn-labs.com
Location: Single
Congr. District: 03
County: Washingto

Phase I

Contract Number: 1R43EB005072-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2005
Phase I Amount
$196,997
This NIH SBIR project intends to develop three product lines of near infrared (NIR) bio-medical labeling reagents based on semiconductor nanocrystals (NIR NanoLabels), including conventional core/shell nanocrystals, type-II core/shell nanocrystals, and quantum well type-ll nanocrystals. NIR fluorescence labels are of great advantages because body tissues are uniquely transparent in this wavelength widow and organic dyes are generally not ideal NIR labeling. The NIR NanoLabels to be developed by this program will be bio-accessible, bio-compatible, photo-stable, chemically stable, bright, and of large absorption cross-section and excitation window. The nanocrystals to be used will include both quantum dot and quantum well structures. The specific aims of this project are 1) produce InAs based core/shell nanocrystals by a one-pot approach and Successive-lonic-Layer-Adsorption-and-Reaction (SILAR). Although InAs/lnP/CdS core/shell nanocrystals are the main target, two other types of potential candidates, InAs/lnP and InAs/CdS core/shell nanocrystals will also be studied. 2). produce CdSe/CdTe or CdTe/CdSe type-ll core/shell nanocrystals by SILAR and develop standard procedures. 3). produce CdS/CdSe/CdTe or CdS/CdTe/CdSe quantum well type-ll nanocrystals by SILAR and develop standard procedures. 4). develop dendron-nanocrystals and box-nanocrystals by chemical modification of these nanocrystals

Phase II

Contract Number: 5R43EB005072-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2006
(last award dollars: 2010)
Phase II Amount
$889,949

This NIH SBIR project intends to develop three product lines of near infrared (NIR) bio-medical labeling reagents based on semiconductor nanocrystals (NIR NanoLabels), including conventional core/shell nanocrystals, type-II core/shell nanocrystals, and quantum well type-ll nanocrystals. NIR fluorescence labels are of great advantages because body tissues are uniquely transparent in this wavelength widow and organic dyes are generally not ideal NIR labeling. The NIR NanoLabels to be developed by this program will be bio-accessible, bio-compatible, photo-stable, chemically stable, bright, and of large absorption cross-section and excitation window. The nanocrystals to be used will include both quantum dot and quantum well structures. The specific aims of this project are 1) produce InAs based core/shell nanocrystals by a one-pot approach and Successive-lonic-Layer-Adsorption-and-Reaction (SILAR). Although InAs/lnP/CdS core/shell nanocrystals are the main target, two other types of potential candidates, InAs/lnP and InAs/CdS core/shell nanocrystals will also be studied. 2). produce CdSe/CdTe or CdTe/CdSe type-ll core/shell nanocrystals by SILAR and develop standard procedures. 3). produce CdS/CdSe/CdTe or CdS/CdTe/CdSe quantum well type-ll nanocrystals by SILAR and develop standard procedures. 4). develop dendron-nanocrystals and box-nanocrystals by chemical modification of these nanocrystals.

Thesaurus Terms:
colloid, fluorescent dye /probe, infrared radiation, microcapsule, molecular probe, nanotechnology, technology /technique development bioimaging /biomedical imaging